Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

NCT00716651

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations: University Hospital Schleswig Holstein, Rheumaklinik Bad Bramstetd Bad Bramstedt, Schleswig-Holstein, Germany

View Trial Details

Completed

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

NCT01387906

Conditions: Hair Diseases, Hemic and Lymphatic Diseases, Hypotrichosis, +11 more
Locations: Kenneth R. Beer, M.D. ,PA West Palm Beach, Florida, United States

View Trial Details

Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations: Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States

Johns Hopkins Oncology Center Baltimore, Maryland, United States

New England Medical Center Hospital Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View all 13 locations

View Trial Details

Completed

Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia

NCT00004898

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

NCT00004907

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00004171

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

NCT00575068

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Research Site Tucson, Arizona, United States

Research Site Rochester, Minnesota, United States

Research Site Buffalo, New York, United States

Research Site Durham, North Carolina, United States

View Trial Details

Completed

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

NCT00004230

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

NCT00005606

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL

NCT00186589

Conditions: Blood and Marrow Transplant (BMT), Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions